RxDoctor Payments Data

Christopher Melroy, MD

Otolaryngology · Savannah, GANPI 1659399368

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $256,150 of the $297,949 with a category attached, or 86.0%. GSK accounts for 98.8% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $96,589, more than ten times the $148 reported in 2019. Among otolaryngology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$297,949in general payments, 2019–2025

Across 360 payments — averaging $827.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$294K
  • Aerin Medical Inc.$969
  • Medtronic$950
  • Regeneron Healthcare Solutions, Inc.$684
  • Integra Lifesciences Corporation$239
  • Acclarent, Inc$189
  • plus $525 from 7 others

What the payments were for

  • Speaking & faculty fees$256,15086%
  • Travel & lodging$32,13011%
  • Food & beverage$9,5053%
  • Education$1640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$297,949 in reported general payments places this provider in the 95th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia

Medicare billing

Part B allowed, 2024
$234,622
Medicare patients
294
Services billed
1,469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab18$67,396
Ipratropium Bromide132$4,776
Azelastine-FluticasoneAzelastine/Fluticasone14$2,637
CefuroximeCefuroxime Axetil38$639
Fluticasone Propionate24$383
Ondansetron OdtOndansetron37$321
Montelukast Sodium15$240
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$182
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$149
Mupirocin18$141
Prednisone53$119
Levocetirizine Dihydrochloride26$106
Azelastine Hcl11$74
Azithromycin12$61
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$59

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →